ResearcherNorth Dakota State UniversityActive in the last 2 years
Priyanka Ray
Matched on ORCID iD 0000-0002-8421-772X; OpenAlex author ID A5002666742. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2019: 3 papers · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers
Papers 6
- pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells … First author DOI 10.1371/journal.pone.0297749↗
- Extracellular Signal-Regulated Kinase Inhibitor SCH772984 Augments the Anti-Cancer Effects of Gemcitabine in Nanoparticle Form in Pancreatic Cancer Models. Co-author DOI 10.22088/ijmcm.bums.13.3.220↗
- pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic Cancer. Co-author DOI 10.1021/acs.molpharmaceut.0c00499↗
- Dendritic Polyglycerol-Derived Nano-Architectures as Delivery Platforms of Gemcitabine for Pancreatic Cancer. Co-author DOI 10.1002/mabi.201900073↗
- Microenvironment-sensing, nanocarrier-mediated delivery of combination chemotherapy for pancreatic cancer. Co-author DOI 10.1007/s12079-019-00514-w↗
- PEG-b-poly (carbonate)-derived nanocarrier platform with pH-responsive properties for pancreatic cancer combination therapy. Co-author DOI 10.1016/j.colsurfb.2018.10.069↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mohiuddin Quadir · 6 shared papers, 2019–2024 · strength 0.94
- Paper Extracellular Signal-Regulated Kinase Inhibitor SCH772984 Augments the Anti-Cancer Effects of Gemcitabine in Nanopartic… DOI 10.22088/ijmcm.bums.13.3.220↗
- Paper pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant… DOI 10.1371/journal.pone.0297749↗
- Paper Dendritic Polyglycerol-Derived Nano-Architectures as Delivery Platforms of Gemcitabine for Pancreatic Cancer. DOI 10.1002/mabi.201900073↗
- Gauthami Nair · 3 shared papers, 2019–2024 · strength 0.49
- Paper Extracellular Signal-Regulated Kinase Inhibitor SCH772984 Augments the Anti-Cancer Effects of Gemcitabine in Nanopartic… DOI 10.22088/ijmcm.bums.13.3.220↗
- Paper pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth i… DOI 10.1021/acs.molpharmaceut.0c00499↗
- Paper Microenvironment-sensing, nanocarrier-mediated delivery of combination chemotherapy for pancreatic cancer. DOI 10.1007/s12079-019-00514-w↗
- Katie M. Reindl · 3 shared papers, 2019–2024 · strength 0.49
- Paper Extracellular Signal-Regulated Kinase Inhibitor SCH772984 Augments the Anti-Cancer Effects of Gemcitabine in Nanopartic… DOI 10.22088/ijmcm.bums.13.3.220↗
- Paper pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth i… DOI 10.1021/acs.molpharmaceut.0c00499↗
- Paper Microenvironment-sensing, nanocarrier-mediated delivery of combination chemotherapy for pancreatic cancer. DOI 10.1007/s12079-019-00514-w↗
- Sushanta K. Banerjee · 3 shared papers, 2019–2024 · strength 0.41
- Paper pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant… DOI 10.1371/journal.pone.0297749↗
- Paper pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth i… DOI 10.1021/acs.molpharmaceut.0c00499↗
- Paper Microenvironment-sensing, nanocarrier-mediated delivery of combination chemotherapy for pancreatic cancer. DOI 10.1007/s12079-019-00514-w↗
- Snigdha Banerjee · 3 shared papers, 2019–2024 · strength 0.41
- Paper pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant… DOI 10.1371/journal.pone.0297749↗
- Paper pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth i… DOI 10.1021/acs.molpharmaceut.0c00499↗
- Paper Microenvironment-sensing, nanocarrier-mediated delivery of combination chemotherapy for pancreatic cancer. DOI 10.1007/s12079-019-00514-w↗
- Sanku Mallik · 3 shared papers, 2019–2021 · strength 0.32
- Paper PEG-b-poly (carbonate)-derived nanocarrier platform with pH-responsive properties for pancreatic cancer combination the… DOI 10.1016/j.colsurfb.2018.10.069↗
- Paper pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth i… DOI 10.1021/acs.molpharmaceut.0c00499↗
- Paper Microenvironment-sensing, nanocarrier-mediated delivery of combination chemotherapy for pancreatic cancer. DOI 10.1007/s12079-019-00514-w↗
- Debasmita Dutta · 2 shared papers, 2021–2024 · strength 0.31
- Paper pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant… DOI 10.1371/journal.pone.0297749↗
- Paper pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth i… DOI 10.1021/acs.molpharmaceut.0c00499↗
- Arnab Ghosh · 2 shared papers, 2019–2024 · strength 0.30
- Paper pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant… DOI 10.1371/journal.pone.0297749↗
- Paper Microenvironment-sensing, nanocarrier-mediated delivery of combination chemotherapy for pancreatic cancer. DOI 10.1007/s12079-019-00514-w↗
- Megan Orr · 1 shared paper, 2021 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.